Up 160% in a year, why this ASX 200 healthcare stock is surging again today

Pro Medicus Limited (ASX: PME) shares are having a good start to the session. In morning trade, the ASX 200 …

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are having a good start to the session.

In morning trade, the ASX 200 healthcare stock is up 3% to $261.50.

This builds on the 160% gain the health imaging technology company's shares had already recorded over the past 12 months.

Why is this ASX 200 healthcare stock surging?

Investors have been bidding the Pro Medicus share price higher today for a couple of reasons.

One reason is that Wall Street rallied higher overnight thanks to the release of favourable inflation data. This is giving the whole market a big boost this morning.

In addition, investors are responding positively to the release of an announcement from the ASX 200 healthcare stock today.

According to the release, the company has signed a $33 million, 9-year contract with the University of Kentucky (UK). It is the preeminent academic health system in the state of Kentucky.

The company notes that UK HealthCare is a comprehensive healthcare system that includes a network of hospitals, clinics, and specialised medical services. It is anchored by the UK Albert B. Chandler Hospital, which is a leading medical facility in the region, offering advanced treatment options and cutting-edge research.

It also highlights that the system includes the UK Good Samaritan Hospital, which provides a range of services including emergency care, surgery, and rehabilitation. Furthermore, it is affiliated with the University of Kentucky College of Medicine, ensuring a strong emphasis on education, research, and innovation.

What's the contract?

The release reveals that the contract is based on a transactional licensing model and will see the company's cloud-based Visage 7 Enterprise Imaging Platform, including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout UK providing a unified diagnostic imaging platform.

Visage will complete the migration from UK's legacy PACS archive and vendor neutral archive to Visage 7 Open Archive. Visage 7 will also provide enterprise distribution of images integrated to UK's electronic health record (EHR).

Commenting on this latest contract win, the ASX 200 healthcare stock's CEO, Dr Sam Hupert, said:

University of Kentucky joins our growing list of academic clients. They also join a long list of Visage 7 clients to opt for a fully cloud-based solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market.

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our "full stack" comprising all three Visage products namely viewer, workflow and archive, a trend we see continuing.

Should you invest $1,000 in CSL right now?

Before you buy CSL shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and CSL wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Share Market News

Which ASX sectors led the pack in March, according to Macquarie?

It was a volatile month for ASX 200 shares...

Read more »

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was rocked by 'Liberation Day' this Thursday.

Read more »

A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.
Superannuation

AustralianSuper sticks with US stocks despite recent turmoil

AustralianSuper’s head of international equities says they won't be shifting focus to Europe.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Opinions

2 compelling ASX shares I'd buy now following the tariff stock market pain

These investments could make excellent buys in the current market sell-off.

Read more »

Child drinking milk out of a glass.
Share Gainers

Guess which ASX All Ords share just rocketed 12% in today's crashing market?

This ASX All Ords share is surging today despite the Trump tariff market turmoil. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Astral, Newmont, Ramelius, and Synlait shares are defying the market selloff and rising

These shares are rising despite the market weakness today. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ANZ, Breville, Cettire, and Treasury Wine shares are dropping today

These shares are having a tough time on Thursday. But why?

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Share Market News

How are ASX 200 investors responding to the new Trump tariffs today?

Australia didn’t escape the new Trump tariffs. Here’s how ASX investors are repositioning today.

Read more »